QuidelOrtho Corp. Hits Day Low of $15.08 Amid Price Pressure

QuidelOrtho Corp., a small-cap player in the Pharmaceuticals & Biotechnology sector, has experienced significant volatility today, with the stock hitting an intraday low of USD 15.08. The company has reported a notable decline of -20.29% in its stock price, contrasting sharply with the S&P 500's performance, which is down only -1.51% for the day. Over the past week, QuidelOrtho's stock has decreased by -15.43%, and its performance over the last month shows a staggering drop of -36.92%. Year-to-date, the stock has plummeted -46.64%, and its one-year performance reflects a decline of -56.32%. This consistent underperformance is evident over a three-year period, where the stock has lost -82.08%, compared to the S&P 500's gain of 64.66%. Financial metrics indicate challenges, with a debt-equity ratio of 138.72% and a low interest coverage ratio of 142.31. The company's return on equity stands at -7.95%, and it has not declared any dividends. QuidelOrtho's stock performance continues to raise concerns, particularly given its negative results over the last 12 consecutive quarters.